1. Home
  2. Author: Michael Zand

All posts by: Michael Zand

About Michael Zand

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell … – News-Medical.net

Bortezomib reduces GVHD, boosts survival for patients receiving stem–cell …News-Medical.netAdding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber …Stem Cell Transplants can be improved by New Drug RegimenTopNews United StatesRx Improved Stem Cell Transplant Success … Continue reading

2013-12-09 NEWS

New collaboration combines genomic sequencing and stem cell technology to … – EurekAlert (press release)

New collaboration combines genomic sequencing and stem cell technology to …EurekAlert (press release)NEW YORK, NY (December 9, 2013) – Today, the New York Stem Cell Foundation (NYSCF) Research Institute and PersonalGenomes.org announced a partnership to identify genetic and environmental contributions to trait and disease development.Priming ‘cocktail’ shows promise as cardiac stem cell grafting toolThe Almagest … Continue reading

2013-12-09 NEWS

Novel drug regimen can improve stem cell transplantation outcomes – Medical Xpress

Novel drug regimen can improve stem cell transplantation outcomesMedical XpressAdding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber …Stem Cell Transplants can be improved by New Drug RegimenTopNews United States all 3 news articles …read … Continue reading

2013-12-08 NEWS